• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Jobs
  • Events

Women’s Health Investment Pulse Check – September 2025

By Femtech Insider Investment, Investment Round-ups, News, Trend Watch October 8, 2025
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Investment, News, Women's Health February 21, 2022
HerMD Adds $10M in Series A Funding to Scale Its Physical Clinics and Launch Virtual Services Throughout the U.S.
Accelerator, Ecosystem, News January 13, 2025
1337 Ventures Launches Southeast Asia’s First Femtech Accelerator Program
Recent Posts
  • Women Are More Comfortable Discussing Their Bodies on Reddit Than With Friends and Family, New Report Finds
  • Elysium Health Pilot Study Links NAD+ Supplementation to Menopause Symptom Relief
  • Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals
  • Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial
  • Muun Health Secures €700K Grant to Advance Wearable Hormone Monitoring Patch

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.